Shang‐Ju Wu

4.5k total citations
95 papers, 2.3k citations indexed

About

Shang‐Ju Wu is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Shang‐Ju Wu has authored 95 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pathology and Forensic Medicine, 28 papers in Genetics and 28 papers in Oncology. Recurrent topics in Shang‐Ju Wu's work include Lymphoma Diagnosis and Treatment (29 papers), Acute Myeloid Leukemia Research (20 papers) and Chronic Lymphocytic Leukemia Research (14 papers). Shang‐Ju Wu is often cited by papers focused on Lymphoma Diagnosis and Treatment (29 papers), Acute Myeloid Leukemia Research (20 papers) and Chronic Lymphocytic Leukemia Research (14 papers). Shang‐Ju Wu collaborates with scholars based in Taiwan, United States and Italy. Shang‐Ju Wu's co-authors include Hwei‐Fang Tien, Jih‐Luh Tang, Ming Yao, Wen‐Chien Chou, Woei Tsay, Chien‐Yuan Chen, Shang‐Yi Huang, Hsin‐An Hou, Mei‐Hsuan Tseng and Bor‐Sheng Ko and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Shang‐Ju Wu

86 papers receiving 2.2k citations

Peers

Shang‐Ju Wu
Susanne Viehmann Germany
Torsten Keßler Germany
Anna Andersson Sweden
Martin Wermke Germany
Hélène A. Poirel Belgium
Tara L. Lin United States
Marc S. Rudoltz United States
Loretta Gammaitoni Italy
Éric Jourdan France
Katharina S. Götze Germany
Susanne Viehmann Germany
Shang‐Ju Wu
Citations per year, relative to Shang‐Ju Wu Shang‐Ju Wu (= 1×) peers Susanne Viehmann

Countries citing papers authored by Shang‐Ju Wu

Since Specialization
Citations

This map shows the geographic impact of Shang‐Ju Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shang‐Ju Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shang‐Ju Wu more than expected).

Fields of papers citing papers by Shang‐Ju Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shang‐Ju Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shang‐Ju Wu. The network helps show where Shang‐Ju Wu may publish in the future.

Co-authorship network of co-authors of Shang‐Ju Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Shang‐Ju Wu. A scholar is included among the top collaborators of Shang‐Ju Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shang‐Ju Wu. Shang‐Ju Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Suh‐Yuen, et al.. (2025). Insights into the transcriptional regulation of CD22 in B cell chronic lymphocytic leukemia. Journal of Biological Chemistry. 301(4). 108386–108386.
2.
Lin, Chien‐Ting, et al.. (2025). The novel CD16A/anti-CD3 bifunctional protein, eCD16A/anti-CD3-BFP, redirects T cell cytotoxicity toward antibody-bound target cells. Human Vaccines & Immunotherapeutics. 21(1). 2447141–2447141.
3.
Hsiao, Yu‐Yu, Yun‐Yu Chen, Shang‐Ju Wu, et al.. (2025). SGLT2i and Cardiovascular Events in Patients With Concomitant Atrial Fibrillation and Diabetes: A TriNetX Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 110(9). 2605–2614. 1 indexed citations
4.
5.
Ma, Weili, Wang-Da Liu, Hsin‐Yun Sun, et al.. (2024). Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan. Journal of Microbiology Immunology and Infection. 57(3). 426–436. 2 indexed citations
6.
7.
Wu, Shang‐Ju, et al.. (2023). Immunotherapeutic potential of blinatumomab-secreting γ9δ2 T Cells. Translational Oncology. 31. 101650–101650. 3 indexed citations
8.
Ma, Weili, Ruey‐Long Hong, Pei‐Jen Lou, et al.. (2023). Improved outcomes of localized diffuse large B‐cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era. Cancer Medicine. 13(1). e6851–e6851. 1 indexed citations
9.
Wu, Hsin‐Yi, Shang‐Ju Wu, Kuen‐Tyng Lin, et al.. (2022). Phosphoproteomics Reveals the Role of Constitutive KAP1 Phosphorylation by B-cell Receptor Signaling in Chronic Lymphocytic Leukemia. Molecular Cancer Research. 20(8). 1222–1232.
10.
Yao, Chi‐Yuan, Chien‐Ting Lin, Marcus J. Calkins, et al.. (2022). Functional association of NR4A3 downregulation with impaired differentiation in myeloid leukemogenesis. Annals of Hematology. 101(10). 2209–2218. 5 indexed citations
11.
Wu, Shang‐Ju, et al.. (2022). Extendable Hybrid Approach to Detect Conscious States in a CLIS Patient Using Machine Learning. SNE Simulation Notes Europe. 32(1). 37–45. 4 indexed citations
12.
Morschhauser, Franck, Carmelo Carlo‐Stella, Michael Dickinson, et al.. (2021). Glofitamab As Monotherapy and in Combination with Obinutuzumab Induces High Complete Response Rates in Patients (pts) with Multiple Relapsed or Refractory (R/R) Follicular Lymphoma (FL). Blood. 138(Supplement 1). 128–128. 20 indexed citations
13.
Huang, Shang‐Yi, Hsiu‐Hsia Lin, Ming Yao, et al.. (2021). Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients. Journal of the Formosan Medical Association. 121(3). 643–651. 1 indexed citations
14.
Cochrane, Tara, Alicia Enrico, David Gómez‐Almaguer, et al.. (2021). Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial. Leukemia & lymphoma. 63(2). 304–314. 6 indexed citations
15.
Wu, Shang‐Ju, Nicoletta Nicolaou, & Martin Bogdan. (2020). Consciousness Detection in a Complete Locked-in Syndrome Patient through Multiscale Approach Analysis. Entropy. 22(12). 1411–1411. 7 indexed citations
16.
17.
Chiou, Hwann‐Kaeo, et al.. (2010). A high performance V-band low noise amplifier using thin-film microstrip (TFMS) lines in 0.13 µm CMOS technology. Asia-Pacific Microwave Conference. 1513–1516. 3 indexed citations
18.
Chen, Chien‐Yuan, Liang‐In Lin, Jih‐Luh Tang, et al.. (2007). RUNX1 gene mutation in primary myelodysplastic syndrome – the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome. British Journal of Haematology. 139(3). 405–414. 88 indexed citations
19.
Chou, Wen‐Chien, Jih‐Luh Tang, Liang‐In Lin, et al.. (2006). Nucleophosmin Mutations in De novo Acute Myeloid Leukemia: The Age-Dependent Incidences and the Stability during Disease Evolution. Cancer Research. 66(6). 3310–3316. 115 indexed citations
20.
Wu, Shang‐Ju, et al.. (1999). Neonatal screening for glucose-6-phosphate dehydrogenase deficiency in Taiwan.. PubMed. 30 Suppl 2. 72–4. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne Viehmann Breakdown of academic impact, for papers by Torsten Keßler Breakdown of academic impact, for papers by Anna Andersson Breakdown of academic impact, for papers by Martin Wermke Breakdown of academic impact, for papers by Hélène A. Poirel Breakdown of academic impact, for papers by Tara L. Lin Breakdown of academic impact, for papers by Marc S. Rudoltz Breakdown of academic impact, for papers by Loretta Gammaitoni Breakdown of academic impact, for papers by Éric Jourdan Breakdown of academic impact, for papers by Katharina S. Götze
Rankless by CCL
2026